Table 3. Single-factor analysis of recurrence and survival rate of colorectal cancer patients [n (%)].
| General information | Cases | Recurrence situation | Survival situation | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Recurrence group (n=89) | No recurrence group (n=202) | χ2 | P | Death group (n=56) | Survival group (n=235) | χ2 | P | |||
| Gender | 0.101 | 0.751 | 0.424 | 0.515 | ||||||
| Male | 161 | 48 (53.93) | 113 (55.94) | 29 (51.79) | 133 (56.60) | |||||
| Female | 130 | 41 (46.07) | 89 (44.06) | 27 (48.21) | 102 (43.40) | |||||
| Age (years) | 1.848 | 0.174 | 0.516 | 0.473 | ||||||
| <60 | 158 | 43 (48.31) | 115 (56.93) | 28 (50.00) | 130 (55.32) | |||||
| ≥60 | 133 | 46 (51.69) | 87 (43.07) | 28 (50.00) | 105 (44.68) | |||||
| Tumor location | 0.191 | 0.662 | 0.369 | 0.544 | ||||||
| Colon | 182 | 54 (60.67) | 128 (63.37) | 37 (66.07) | 145 (61.70) | |||||
| Rectum | 109 | 35 (39.33) | 74 (36.63) | 19 (33.93) | 90 (38.30) | |||||
| TNM staging | 8.223 | 0.004 | 2.693 | 0.101 | ||||||
| I–II | 111 | 23 (25.84) | 88 (43.56) | 16 (28.57) | 95 (40.43) | |||||
| III–IV | 180 | 66 (74.16) | 114 (56.44) | 40 (71.43) | 140 (59.57) | |||||
| Differentiated degree | 6.346 | 0.012 | 7.988 | 0.005 | ||||||
| Moderate and high differentiation | 206 | 54 (60.67) | 152 (75.25) | 31 (55.36) | 175 (74.47) | |||||
| Poor differentiation | 85 | 35 (39.33) | 50 (24.75) | 25 (44.64) | 60 (25.53) | |||||
| Pathological type | 2.183 | 0.140 | 1.794 | 0.180 | ||||||
| Adenocarcinoma | 213 | 60 (67.42) | 153 (75.74) | 37 (66.07) | 176 (74.89) | |||||
| Others | 78 | 29 (32.58) | 49 (24.26) | 19 (33.93) | 59 (25.11) | |||||
| Tumor type | 3.084 | 0.214 | 1.662 | 0.436 | ||||||
| Infiltrating type | 25 | 7 (7.87) | 18 (8.91) | 3 (5.36) | 22 (9.36) | |||||
| Ulcerative type | 157 | 42 (47.19) | 115 (56.93) | 34 (60.71) | 123 (52.34) | |||||
| Protrude type | 109 | 40 (44.94) | 69 (34.16) | 19 (33.93) | 90 (38.30) | |||||
| Lymph node metastasis | 11.109 | 0.001 | 9.932 | 0.002 | ||||||
| Yes | 94 | 41 (46.08) | 53 (26.24) | 28 (50.00) | 66 (28.09) | |||||
| No | 197 | 48 (53.93) | 149 (73.76) | 28 (50.00) | 169 (71.91) | |||||
| Vascular carcinoma thrombus | 6.699 | 0.010 | 5.758 | 0.016 | ||||||
| Yes | 64 | 28 (31.46) | 36 (17.82) | 19 (33.93) | 45 (19.15) | |||||
| No | 227 | 61 (68.54) | 166 (82.18) | 37 (66.07) | 190 (80.85) | |||||
| Omentin-1 level (ng/mL) | 17.605 | <0.001 | 11.472 | 0.001 | ||||||
| <50 | 85 | 11 (12.36) | 74 (36.63) | 6 (10.71) | 79 (33.62) | |||||
| ≥50 | 206 | 78 (87.64) | 128 (63.37) | 50 (89.29) | 156 (66.38) | |||||